Immunostaining for OX-42 and GFAP was used to assess the pathological changes of microglia and astrocytes, respectively, which are involved in the neuroinflammatory processes after cerebral ischemia-reperfusion. The gene discussed is GFAP; the disease is Cerebral ischemia.